Melatonin use in clinical psychiatry currently is rife. Efficacy coupled with safety and lack of abuse potential render melatonin an attractive therapeutic option. Data accrues speaking to the idea of a pluripotent molecule beyond a sleep-aid. Here, authors would shed some light on melatonin use in psychiatry.
| Published in | International Journal of Psychological and Brain Sciences (Volume 1, Issue 2) |
| DOI | 10.11648/j.ijpbs.20160102.12 |
| Page(s) | 29-31 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2016. Published by Science Publishing Group |
Melatonin, ASD, ADHD, Bipolar, Schizophrenia, AD, TD, Metabolic Syndrome
| [1] | Sanchez-Barcelo EJ, Mediavilla MD, Reiter RJ. Clinical Uses of Melatonin in Pediatrics. Int J Pediatr. 2011; 2011: 892624. |
| [2] | Wright B, Sims D, Smart S, et al. Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. J Autism Dev Disord. 2011; 41 (2): 175-84. |
| [3] | Malow BA, Adkins KW, Mc Grew SG, et al. Melatonin for Sleep in Children with Autism: A Controlled Trial Examining Dose, Tolerability, and Outcomes. J Autism Dev Disord. 2012; 42 (8): 1729-1737 |
| [4] | Van der Heijden KB, Smits MG, Van Someren EJ, et al. Effect of melatonin on sleep, behaviour, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry. 2007; 46 (2): 233-41. |
| [5] | Niederhofer H, Staffen W, Mair A, et al. Brief report: melatonin facilitates sleep in individuals with mental retardation and insomnia. J Autism Dev Disord. 2003; 33 (4): 469-72. |
| [6] | Jain S, Besag FM. Does Melatonin affect epileptic seizures? Drug Saf. 2013; 36 (4): 207-15. |
| [7] | Naguy A, Francis K. Melatonin: A New Game-Changer in Juvenile Bipolar Disorders? Psychiatr Res. 2016 (in Press). |
| [8] | Bersani, G., Garavini, A. Melatonin add-on in manic patients with treatment resistent insomnia. Prog Neuropsychopharmacol Biol Psychiatry. 2000; 24 (2): 185-91. |
| [9] | Robertson JM, Tanguay PE. Case Study: The Use of Melatonin in a Boy With Refractory Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 1997; 36 (6): 822-825. |
| [10] | Anderson, G., Maes, M. Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects. Metab Brain Dis. 2012; 27 (2): 113-119. |
| [11] | Morera-Fumero AL, Abreu-Gonzalez P. Role of Melatonin in Schizophrenia. Int J Mol Sci. 2013; 14 (5): 9037-9050. |
| [12] | Cardinali DP, Furio AM, Brusco LI. Clinical Aspects of Melatonin Intervention in Alzheimer’s Disease Progression. Curr Neuropharmacol 2010; 8 (3): 218-227. |
| [13] | Chen S, Shi L, Liang F, et al. Exogenous Melatonin for Delirium Prevention: a Meta-analysis of Randomized Controlled Trials. Mol Neurobiol. 2016; 53 (6): 4046-53. |
| [14] | Shamir E, Barak Y, Shalman I, et al. Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Arch Gen Psychiatry. 2001; 58 (11): 1049-52. |
| [15] | Romo-Nava, F., Gonzalez, D., Fresan-Orellana, A., et al. Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial. Bipolar Disord. 2014; 16 (4): 410-421. |
| [16] | Goyal, A., Terry, P. D., Superak, H. M et al. Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial. Diabetol Met Synd. 2014; 6: 124. |
APA Style
Ahmed Naguy, Pavly Samir. (2016). Melatonin “Pearls” in Psychiatry. International Journal of Psychological and Brain Sciences, 1(2), 29-31. https://doi.org/10.11648/j.ijpbs.20160102.12
ACS Style
Ahmed Naguy; Pavly Samir. Melatonin “Pearls” in Psychiatry. Int. J. Psychol. Brain Sci. 2016, 1(2), 29-31. doi: 10.11648/j.ijpbs.20160102.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijpbs.20160102.12,
author = {Ahmed Naguy and Pavly Samir},
title = {Melatonin “Pearls” in Psychiatry},
journal = {International Journal of Psychological and Brain Sciences},
volume = {1},
number = {2},
pages = {29-31},
doi = {10.11648/j.ijpbs.20160102.12},
url = {https://doi.org/10.11648/j.ijpbs.20160102.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijpbs.20160102.12},
abstract = {Melatonin use in clinical psychiatry currently is rife. Efficacy coupled with safety and lack of abuse potential render melatonin an attractive therapeutic option. Data accrues speaking to the idea of a pluripotent molecule beyond a sleep-aid. Here, authors would shed some light on melatonin use in psychiatry.},
year = {2016}
}
TY - JOUR T1 - Melatonin “Pearls” in Psychiatry AU - Ahmed Naguy AU - Pavly Samir Y1 - 2016/09/07 PY - 2016 N1 - https://doi.org/10.11648/j.ijpbs.20160102.12 DO - 10.11648/j.ijpbs.20160102.12 T2 - International Journal of Psychological and Brain Sciences JF - International Journal of Psychological and Brain Sciences JO - International Journal of Psychological and Brain Sciences SP - 29 EP - 31 PB - Science Publishing Group SN - 2575-1573 UR - https://doi.org/10.11648/j.ijpbs.20160102.12 AB - Melatonin use in clinical psychiatry currently is rife. Efficacy coupled with safety and lack of abuse potential render melatonin an attractive therapeutic option. Data accrues speaking to the idea of a pluripotent molecule beyond a sleep-aid. Here, authors would shed some light on melatonin use in psychiatry. VL - 1 IS - 2 ER -
Information
Email: